Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Abilify

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Abilify was produced by Otsuka and Bristol-Myers Squibb.

Ten new medicines recommended in Europe

Ten new medicines recommended in Europe This is a copycat version of Bristol-Myers Squibb/Otsuka's blockbuster Abilify (aripiprazole), which made $5.5bn last year, but is now starting to succumb to generic erosion.

Pfizer maintains lead in top CNS drug sales - just

Pfizer maintains lead in top CNS drug sales - just Otsuka's anti-psychotic drug Abilify (aripiprazole), which the company co-markets with Bristol-Myers Squibb, was once the sales leader in the CNS arena but it is now being hit

Schultz takes Lundbeck helm after leaving Novo Nordisk

Schultz takes Lundbeck helm after leaving Novo Nordisk Some of the central nervous system (CNS) drug developer's newer products showed encouraging signs in the first quarter, with sales of depot schizophrenia drug Abilify Maintena (aripiprazole) almost quadrupling to

BMS shines in Q1, but Abilify generics cast a long shadow

BMS shines in Q1, but Abilify generics cast a long shadow Bristol-Myers Squibb (BMS) posted a buoyant set of results in the first quarter, although the approval of generics to $8bn blockbuster Abilify in the US muted celebrations. ... BMS earns royalties on Abilify sales and the company reported revenues of

Takeda's once-weekly DPP-4 inhibitor cleared in first market

Takeda's once-weekly DPP-4 inhibitor cleared in first market Otsuka has been given a green light to market a new once-monthly formulation of schizophrenia treatment Abilify (aripiprazole) that has been on the market in the US since 2013 and ... Europe since 2014 as Abilify Maintena.

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Wisepress

Wisepress is a medical bookseller promoting and selling books worldwide, both online and via the 200 European medical conferences that...

Latest intelligence

Three billboards on the road to multichannel
Chris Ross examines the trends driving multichannel communication in 2019...
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....
Cell and gene therapy
Tackling the manufacturing cost and complexity challenges...

Infographics